Meloxicam Tablets (meloxicam ) - new on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - January 12, 2017 Category: Drugs & Pharmacology Source Type: news
Recro Pharma Appoints Michael Celano as Chief Financial Officer
MALVERN, Pa., July 05, 2016 -- (Healthcare Sales & Marketing Network) -- Recro Pharma, Inc. (REPH), a revenue generating specialty pharmaceutical company developing multiple non-opioid therapeutics for the treatment of pain, today announced the appointment... Biopharmaceuticals, PersonnelRecro Pharma, Meloxicam, dexmedetomidine (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - July 5, 2016 Category: Pharmaceuticals Source Type: news
Mobic (Meloxicam) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - May 23, 2016 Category: Drugs & Pharmacology Source Type: news
VIVLODEX(TM) Now Available in U.S. Pharmacies for the Management of Osteoarthritis Pain
Third Low-Dose SoluMatrix® NSAID from Iroko Now Available by Prescription
PHILADELPHIA, Feb. 16, 2016 -- (Healthcare Sales & Marketing Network) -- Iroko Pharmaceuticals, LLC, a global specialty pharmaceutical company dedicated to advancing the scie... Biopharmaceuticals, Product LaunchIroko Pharmaceuticals, VIVLODEX, meloxicam, NSAID (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - February 16, 2016 Category: Pharmaceuticals Source Type: news
Recro Pharma Appoints Fred Graff as Chief Commercial Officer
MALVERN, Pa., Feb. 16, 2016 -- (Healthcare Sales & Marketing Network) -- Recro Pharma, Inc. (REPH), a revenue generating specialty pharmaceutical company developing multiple non-opioid therapeutics for the treatment of pain, today announced the appointment... Biopharmaceuticals, PersonnelRecro Pharma, Meloxicam, dexmedetomidine (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - February 16, 2016 Category: Pharmaceuticals Source Type: news
Recro Pharma begins dosing in Phase III trial of IV meloxicam to manage acute postoperative pain
US-based Recro Pharma has started a Phase III clinical trial of intravenous (IV) meloxicam (N1539) to treat acute postoperative pain in patients. (Source: Drug Development Technology)
Source: Drug Development Technology - February 2, 2016 Category: Pharmaceuticals Source Type: news
Vivlodex (Meloxicam Capsules) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - November 9, 2015 Category: Drugs & Pharmacology Source Type: news
Iroko Pharmaceuticals Receives FDA Approval For VIVLODEX - First Low Dose SoluMatrix Meloxicam For Osteoarthritis Pain
Iroko Pharmaceuticals, LLC, a global specialty pharmaceutical company dedicated to advancing the science of analgesia, announced recently that the United States Food and Drug Administration (FDA) approved VIVLODEX (meloxicam) capsules, a nonsteroidal anti-inflammatory drug (NSAID), for the management of osteoarthritis pain in 5 mg and 10 mg doses administered once daily. (Source: Pharmaceutical Online News)
Source: Pharmaceutical Online News - October 26, 2015 Category: Pharmaceuticals Source Type: news
Iroko Pharmaceuticals Receives FDA Approval for VIVLODEX(TM) - First Low Dose SoluMatrix(R) Meloxicam for Osteoarthritis Pain
VIVLODEX Developed to Align with FDA NSAID Recommendations
Proven Efficacy at Low Doses
PHILADELPHIA, Oct. 23, 2015 -- (Healthcare Sales & Marketing Network) -- Iroko Pharmaceuticals, LLC, a global specialty pharmaceutical company dedicated to advan... Biopharmaceuticals, FDAIroko Pharmaceuticals, VIVLODEX, meloxicam, NSAID, osteoarthritis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - October 23, 2015 Category: Pharmaceuticals Source Type: news
Recro Pharma Acquires Certain Alkermes' Assets
Recro acquisition includes worldwide rights to IV/IM meloxicam and contract manufacturing facility in Gainesville, Georgia (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - April 15, 2015 Category: Pharmaceuticals Source Type: news
Patent Issued for Research Related to Alleviating Pain in Cattle
A patent has been issued for research that alleviates pain in cattle suffering from lameness and following castration, dehorning. The patent covers administering meloxicam alone or administering a combination of meloxicam and gabapentin to help alleviate acute and chronic pain and improve the performance of cattle. Researchers found that combinations of meloxicam and gabapentin improved the welfare of cattle by reducing the severity of lameness. Meloxicam alone improved weight gain after dehorning and reduced the incidence of bovine respiratory disease after castration. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - August 27, 2014 Category: Science Source Type: news
SoluMatrix(R) Meloxicam Demonstrates Significant Efficacy at 30 Percent Lower Doses in the Treatment of Osteoarthritis
Phase 3 Data Presented at EULAR 2014
PHILADELPHIA--(Healthcare Sales & Marketing Network)--Iroko Pharmaceuticals, LLC, a global specialty pharmaceutical company dedicated to advancing the science of analgesia, today will present Phase 3 results that sho... BiopharmaceuticalsIroko Pharmaceuticals, SoluMatrix, meloxicam, osteoarthritis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 12, 2014 Category: Pharmaceuticals Source Type: news
meloxicam, Mobic
Title: meloxicam, MobicCategory: MedicationsCreated: 11/8/2000 8:38:00 PMLast Editorial Review: 10/11/2013 12:00:00 AM (Source: MedicineNet Arthritis General)
Source: MedicineNet Arthritis General - October 11, 2013 Category: Rheumatology Source Type: news
meloxicam, Mobic
Title: meloxicam, MobicCategory: MedicationsCreated: 11/8/2000 8:38:00 PMLast Editorial Review: 10/11/2013 12:00:00 AM (Source: MedicineNet Medications General)
Source: MedicineNet Medications General - October 11, 2013 Category: Drugs & Pharmacology Source Type: news
